Suppr超能文献

马耳他内脏利什曼病——一项基于人群的18年儿科研究。

Visceral leishmaniasis in Malta--an 18 year paediatric, population based study.

作者信息

Grech V, Mizzi J, Mangion M, Vella C

机构信息

Paediatric Department, St Luke's Hospital Guardamangia, Malta.

出版信息

Arch Dis Child. 2000 May;82(5):381-5. doi: 10.1136/adc.82.5.381.

Abstract

BACKGROUND

Visceral leishmaniasis (VL) is a chronic parasitic infection that infects approximately 400,000 individuals annually, with a predilection towards early childhood.

AIMS

To study the epidemiology of VL in childhood.

METHODS

VL is endemic in Malta, a small archipelago of islands in the centre of the Mediterranean with a total population approaching half a million. Notification of human cases of leishmaniasis is compulsory. Case records of all 81 paediatric patients with VL between 1980 and 1998 were analysed.

RESULTS

The annual incidence of VL declined for all cases of VL, and declined significantly for paediatric cases (p = 0.01). For 1994 to 1998, the overall incidence of VL was 0.9 per 100,000 total population and the paediatric incidence was 2.5 per 100,000 population. Median age at presentation was 34 months. Common features at presentation were splenomegaly, hepatomegaly, fever, and pancytopenia with high lymphocyte and monocyte counts. The diagnostic sensitivity of isolated immunofluorescent antibody testing was equivalent to bone marrow aspiration (95%). Blood transfusions for anaemia were required in 93% of patients. Eleven per cent had intercurrent infections. All patients were cured, and were initially treated with intravenous sodium stibogluconate. Defervescence occurred after a median of six days of treatment, and patients continued to be treated on a day case basis. Nine relapsers were retreated with sodium stibogluconate, achieving a cure rate of 94%, but five patients required additional drug therapy. There were no permanent sequelae associated with VL or its treatment.

CONCLUSIONS

The decreased incidence is attributed to the eradication of stray dogs which are the disease reservoir.

摘要

背景

内脏利什曼病(VL)是一种慢性寄生虫感染,每年感染约40万人,发病高峰在儿童早期。

目的

研究儿童期VL的流行病学。

方法

VL在马耳他呈地方性流行,马耳他是地中海中部的一个小群岛,总人口近50万。利什曼病的人类病例通报是强制性的。分析了1980年至1998年间81例儿童VL患者的病例记录。

结果

所有VL病例的年发病率均下降,儿童病例显著下降(p = 0.01)。1994年至1998年,VL的总体发病率为每10万人0.9例,儿童发病率为每10万人2.5例。就诊时的中位年龄为34个月。就诊时的常见特征为脾肿大、肝肿大、发热和全血细胞减少伴淋巴细胞和单核细胞计数升高。间接免疫荧光抗体检测的诊断敏感性与骨髓穿刺相当(95%)。93%的患者因贫血需要输血。11%的患者有并发感染。所有患者均治愈,最初接受静脉注射葡萄糖酸锑钠治疗。治疗中位数6天后退热,患者继续在日间病房接受治疗。9例复发患者再次接受葡萄糖酸锑钠治疗,治愈率为94%,但5例患者需要额外的药物治疗。VL及其治疗未产生永久性后遗症。

结论

发病率下降归因于作为疾病储存宿主的流浪狗的根除。

相似文献

2
Leishmaniasis in Malta and the Mediterranean basin.马耳他及地中海盆地的利什曼病
Ann Trop Med Parasitol. 1997 Oct;91(7):747-53. doi: 10.1080/00034989760491.
3
Visceral childhood leishmaniasis in Turkey.土耳其的儿童内脏利什曼病
Acta Paediatr. 2002;91(1):62-4. doi: 10.1080/080352502753457978.
4
Manifestations of paediatric Leishmania infantum infections in Malta.马耳他小儿利什曼原虫感染的表现。
Travel Med Infect Dis. 2011 Jan;9(1):37-46. doi: 10.1016/j.tmaid.2010.11.005. Epub 2011 Jan 5.
9
Epidemiology of visceral leishmaniasis in Algeria: an update.阿尔及利亚内脏利什曼病的流行病学:最新情况
PLoS One. 2014 Jun 20;9(6):e99207. doi: 10.1371/journal.pone.0099207. eCollection 2014.

引用本文的文献

3
Pediatric visceral leishmaniasis in Tartous, Syria.叙利亚塔尔图斯的小儿内脏利什曼病
Avicenna J Med. 2020 Oct 13;10(4):223-226. doi: 10.4103/ajm.ajm_168_20. eCollection 2020 Oct-Dec.
4
Pediatric visceral leishmaniasis in northwest of Iran.伊朗西北部的小儿内脏利什曼病
Medicine (Baltimore). 2016 Nov;95(44):e5261. doi: 10.1097/MD.0000000000005261.
6
From the dermatologikum hamburg: quiz.来自汉堡皮肤病医院:测验。
Dermatol Pract Concept. 2013 Jan 31;3(1):21-3. doi: 10.5826/dpc.0301a06. Print 2013 Jan.
7
Manifestations of paediatric Leishmania infantum infections in Malta.马耳他小儿利什曼原虫感染的表现。
Travel Med Infect Dis. 2011 Jan;9(1):37-46. doi: 10.1016/j.tmaid.2010.11.005. Epub 2011 Jan 5.
8
Leishmaniasis.利什曼病
Postgrad Med J. 2007 Feb;83(976):649-57. doi: 10.1136/pgmj.2006.047340corr1.
9
Leishmaniasis.利什曼病
Postgrad Med J. 2006 Oct;82(972):649-57. doi: 10.1136/pgmj.2006.047340.

本文引用的文献

1
The recognition and estimation of cyclic trends.周期性趋势的识别与评估。
Ann Hum Genet. 1961 May;25:83-7. doi: 10.1111/j.1469-1809.1961.tb01501.x.
3
Trial of oral miltefosine for visceral leishmaniasis.口服米替福新治疗内脏利什曼病的试验。
Lancet. 1998 Dec 5;352(9143):1821-3. doi: 10.1016/S0140-6736(98)04367-0.
4
Pediatric visceral leishmaniasis in southern France.法国南部的儿童内脏利什曼病
Pediatr Infect Dis J. 1998 Aug;17(8):701-4. doi: 10.1097/00006454-199808000-00008.
6
Leishmaniasis in Malta and the Mediterranean basin.马耳他及地中海盆地的利什曼病
Ann Trop Med Parasitol. 1997 Oct;91(7):747-53. doi: 10.1080/00034989760491.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验